(Q45363416)

English

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation

scientific article published on 13 September 2011

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Pre-emptive rituximab based on viraemia and T cell reconstitution: a highly effective strategy for the prevention of Epstein-Barr virus-associated lymphoproliferative disease following stem cell transplantation (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

1 reference

based on heuristic

inferred from title

Epstein–Barr virus

0 references

1

object named as

Austen Worth

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

author name string

Rachel Conyers

2

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Jonathon Cohen

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Mamta Jagani

4

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Robert Chiesa

5

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Kanchana Rao

6

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Nicholas Goulden

7

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Paul Veys

8

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Persis J Amrolia

9

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

language of work or name

0 references

publication date

13 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

155

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

377-385

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

Marked increased risk of Epstein-Barr virus-related complications with the addition of antithymocyte globulin to a nonmyeloablative conditioning prior to unrelated umbilical cord blood transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Incidence and dynamics of Epstein-Barr virus reactivation after alemtuzumab-based conditioning for allogeneic hematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Reconstitution of the Epstein-Barr virus-specific cytotoxic T-lymphocyte response following T-cell-depleted myeloablative and nonmyeloablative allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Increased incidence of EBV-related disease following paediatric stem cell transplantation with reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Epstein-Barr virus (EBV) reactivation is a frequent event after allogeneic stem cell transplantation (SCT) and quantitatively predicts EBV-lymphoproliferative disease following T-cell--depleted SCT.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Prevention of Epstein-Barr virus-lymphoproliferative disease by molecular monitoring and preemptive rituximab in high-risk patients after allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Chimaeric anti-CD20 monoclonal antibody (rituximab) in post-transplant B-lymphoproliferative disorder following stem cell transplantation in children.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

How I treat EBV lymphoproliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Normalized quantification by real-time PCR of Epstein-Barr virus load in patients at risk for posttransplant lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Impaired recovery of Epstein-Barr virus (EBV)--specific CD8+ T lymphocytes after partially T-depleted allogeneic stem cell transplantation may identify patients at very high risk for progressive EBV reactivation and lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Single agent efficacy of rituximab in childhood immunosuppression related lymphoproliferative disease: a United Kingdom Children's Cancer Study Group (UKCCSG) retrospective review

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Use of gene-modified virus-specific T lymphocytes to control Epstein-Barr-virus-related lymphoproliferation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Epstein-Barr virus monitoring in paediatric renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

A prospective study of Epstein-Barr virus load in 85 hematopoietic stem cell transplants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2011.08855.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2011.08855.X

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

release_4zt2mvddgjhexjjelzznvpe7di

1 reference

https://api.fatcat.wiki/v0/release/4zt2mvddgjhexjjelzznvpe7di

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45363416&oldid=2151681122"